CMS advises Bruker technology company in its acquisition of Prolab

Bruker, a NASDAQ-listed technology company in the analytical instrumentation sector, has acquired Prolab. 

Prolab, founded in 1988 and headquartered in Reinach, specialises in high-precision low-flow liquid chromatography technology. In this context, the company focuses primarily on micro- and nano-UHPLC pump technology. 

The acquisition of Prolab provides Bruker with the opportunity to accelerate product innovation. In addition, Prolab’s injection technology on the Zirconium Qube Autosampler enables high-precision injections with the smallest sample volumes and minimal sample losses, as well as faster cycle times. Therefore, the acquisition of Prolab ideally complements Bruker’s high-performance mass spectrometry systems. 

A team from CMS Switzerland, led by partner Stefan Brunnschweiler (corporate/m&a, pictured), advised Bruker on all legal matters of the transaction. CMS Switzerland team also included associate Pascal Stocker (corporate/m&a), counsel Simone Brauchbar Birkhäuser (IP/IT), associate Alexandra Stocker (corporate) and commercial partner Marjolaine Jakob. The CMS Switzerland team was also joined by members of CMS Germany.

 

 

FabioAdmin

SHARE